GNH USA

Europe — EMA

Linatra

GNH USA supplies Linatra (Linagliptin), a DPP‑4 inhibitor for type 2 diabetes mellitus, meeting EU quality standards. Request a quote for global supply.

Linagliptin

Request sourcing

1
Pack/s

What is Linagliptin?

Linagliptin, the active ingredient in Linatra, is a DPP-4 inhibitor presented as an oral tablet for oral use. It is indicated for the management of type 2 diabetes mellitus in adults.

GNH USA supplies Linatra as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for patients and healthcare providers across multiple regions.

What is Linagliptin used for?

Linagliptin acts on the incretin pathway to improve glycemic control in type 2 diabetes mellitus.

- Type 2 diabetes mellitus (monotherapy): improves glycemic control as a single agent. - Type 2 diabetes mellitus (combination therapy): used with metformin or other antidiabetics to enhance glucose control. - Type 2 diabetes mellitus (renal impairment): provides effective glycemic control without dose adjustment in patients with renal impairment.

What are the side effects of Linagliptin?

Common Side Effects: - Nasopharyngitis: mild upper respiratory tract infection. - Headache: transient mild to moderate headache. - Upper respiratory infection: symptoms of cough and sore throat. - Dizziness: occasional light‑headedness. - Gastrointestinal discomfort: nausea or abdominal pain.

Serious or Rare Side Effects: - Pancreatitis: severe abdominal pain requiring immediate medical attention. - Severe hypersensitivity reactions: rash, angioedema, or anaphylaxis. - Hepatic injury: elevated liver enzymes or jaundice. - Bullous pemphigoid: blistering skin disorder. - Severe allergic reactions: urticaria or bronchospasm.

What precautions apply to Linagliptin?

Linagliptin should be used with caution in specific patient populations and clinical situations. - Renal function: no dose adjustment required, but monitor renal status regularly. - Hepatic impairment: use with caution and monitor liver function tests. - Hypersensitivity: discontinue immediately if allergic reactions occur. - Pregnancy: safety not established; avoid unless benefit outweighs potential risk. - Elderly patients: monitor for adverse reactions due to possible comorbidities. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

What does Linagliptin interact with?

Linagliptin may interact with several medicines that affect its plasma concentration or pharmacodynamic response.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase linagliptin exposure and risk of side effects. - Strong CYP3A4 inducers: may reduce linagliptin effectiveness. - Insulin secretagogues (e.g., sulfonylureas): increased risk of hypoglycemia.

Moderate Interactions (Monitor Closely): - Diuretics: may diminish antihyperglycemic effect of linagliptin. - Rifampin: can lower linagliptin plasma levels, reducing efficacy.

Frequently asked questions

What is Linatra used for?+
Linatra contains linagliptin, a DPP‑4 inhibitor prescribed to improve blood glucose control in adults with type 2 diabetes mellitus, either as monotherapy or in combination with other antidiabetic agents.
How does linagliptin work?+
Linagliptin selectively blocks the DPP‑4 enzyme, which normally degrades the incretin hormones GLP‑1 and GIP. By preserving these hormones, it enhances glucose‑dependent insulin release, reduces glucagon secretion, and helps lower post‑prandial blood glucose levels.
What is the usual dose of Linatra?+
The prescribed dose of Linatra is determined by the treating physician based on the individual’s clinical condition, renal and hepatic function, and concomitant therapies. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Linatra safe during pregnancy or breastfeeding?+
Safety of linagliptin in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.
How do I order Linatra from GNH USA?+
To place an order, submit an enquiry on the Linatra product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Linatra compare with other DPP‑4 inhibitors?+
Linagliptin differs from many other DPP‑4 inhibitors because it does not require dose adjustment in renal impairment, owing to its primarily non‑renal elimination. Efficacy and safety profiles are comparable, but the lack of renal dosing changes can simplify treatment in patients with reduced kidney function.
What are the storage and handling requirements for Linatra?+
Linatra should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability throughout its shelf life.
How is Linatra administered?+
Linatra is taken orally, usually once daily, with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with water and not crushed or chewed unless specifically instructed.
What are the most serious risks associated with Linatra?+
Serious risks include pancreatitis, severe hypersensitivity reactions such as anaphylaxis, and rare skin disorders like bullous pemphigoid. Patients should seek immediate medical attention if they experience persistent abdominal pain, rash, swelling, or breathing difficulties.
Who should not use Linatra?+
Linatra is contraindicated in individuals with known hypersensitivity to linagliptin or any component of the formulation. Caution is also advised for patients with a history of pancreatitis or severe hepatic disease, and it should be avoided in pregnancy unless clearly indicated by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Linagliptin
Route
Oral Use
Manufacturer
Zaklady Farmaceutyczne Polpharma S.A.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU